Table 1 Characteristics of the 109 patients included in the analysis
Age (Median, range) | 59 | 30-79 |
|---|---|---|
| Â | n | (%) |
Sex | Â | Â |
   Male | 80 | (73) |
   Female | 29 | (27) |
Nephrectomy | Â | Â |
   No | 23 | (21) |
   Yes | 86 | (79) |
Time between diagnosis and Sutent initiation | Â | Â |
   <= 12 months | 53 | (49) |
   >12 months | 54 | (49) |
   Unknown | 2 | (2) |
Histology | Â | Â |
   Clear Cell | 100 | (91) |
   Papillary | 2 | (2) |
   Chromophobe | 2 | (2) |
   Mixed | 3 | (3) |
   Unclassified | 2 | (2) |
Performance Status | Â | Â |
   0 | 59 | (54) |
   1 | 37 | (34) |
   2 | 13 | (12) |
Number of Metastatic sites | Â | Â |
   1 | 32 | (29) |
   >1 | 77 | (71) |
Site of metastatic disease | Â | Â |
   Lung | 75 | (69) |
   Nodes | 38 | (35) |
   Liver | 10 | (9) |
   Renal bed | 27 | (25) |
   Bones | 39 | (36) |
   Brain | 8 | (7) |
Hb | Â | Â |
   Median (range) | 12.1 | (8.6-17.9) |
   <13 for Males, <11.5 for Females | 57 | (52) |
   >= 13 for Males, >= 11.5 for Females | 50 | (46) |
   Unknown | 2 | (2) |
Ca | Â | Â |
   Median (range) | 9.4 | (1.0-12.1) |
   <10 | 85 | (78) |
   >= 10 | 16 | (15) |
   Unknown | 8 | (7) |
LDH | Â | Â |
   Normal | 58 | (53) |
   Abnormal | 38 | (35) |
   Unknown | 13 | (12) |
ALP | Â | Â |
   Normal | 74 | (68) |
   Abnormal | 29 | (27) |
   Unknown | 6 | (5) |